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Abstract
The aim of this case report is to assess the potential role of intrarenal Doppler ultrasonography as a non-invasive method to
evaluate intrarenal venous flow (IRVF) in acute heart failure (AHF) and concomitant renal dysfunction. We report a case of an
81-year-old woman with valvular heart disease (previous mitral valve replacement) that presented with acutely decompen-
sated heart failure and concomitant worsening renal function (WRF). In addition to complete physical examination, laboratory
analysis, and echocardiography, IRVF was assessed at baseline and 48 h after the administration of diuretic treatment. At
admission, physical examination and echocardiography revealed signs of intravascular congestion (jugular venous distension
and severely dilated inferior vena cava). In addition, a significant increase in serum creatinine from 1.23 to 1.81 mg/dL was
noted without signs of hypoperfusion at clinical evaluation. At baseline, intrarenal Doppler ultrasonography showed a
monophasic IRVF pattern indicating a severely elevated interstitial renal pressure. After aggressive decongestion, a dynamic
behaviour was found in IRVF changing from monophasic to biphasic pattern in parallel with an improvement in clinical param-
eters and renal function (serum creatinine changed from 1.81 to 1.44 mg/dL). In this case of a patient with AHF and WRF, IRVF
changed after aggressive decongestion in agreement with clinical evolution. According to these findings, this technique could
provide valuable information for identifying patients with a ‘congestion kidney failure’ phenotype. Further studies are needed
confirming this observation and evaluating the potential role of this technique for guiding decongestive therapy in patients
with AHF and WRF.
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Introduction
Worsening renal function (WRF) in acutely decompensated
heart failure (ADHF) was classically attributed to reduced
cardiac output and intravascular volume depletion second-
ary to the use of diuretics. However, recent evidence has
challenged this notion and postulate venous renal conges-
tion as a key component of the cardiorenal interaction in
ADHF.1,2 However, there is a lack of well-stablished tools
for distinguishing between both haemodynamic phenotypes.
Recently, intriguing data suggest the potential role of
intrarenal Doppler venous flow patterns (IRVF) assessed by
echography as an attractive tool to better understand
intrarenal haemodynamics.3,4
Case report
We report a case of an 81-year-old woman with valvular
heart disease (previous mitral valve replacement) that pre-
sented with increased dyspnoea, abdominal discomfort, and
1.5 kg weight gain. Ambulatory daily heart failure treatment
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was bisoprolol 1.25 mg, furosemide 160 mg, chlorthalidone
25 mg, acetazolamide 125 mg, and spironolactone 12.5 mg.
No evident cause for clinical decompensation was noted. Vital
signs at presentation were as follows: heart rate 69 bpm, arte-
rial blood pressure 90/56 mmHg (usual values and no signs of
hypoperfusion), respiration rate 19 per minute, and capillary
Sa02 96%. The physical examination revealed abdominal and
jugular venous distension, positive hepatojugular reflux, but
no peripheral oedema nor rales. Echocardiography showed a
normally functioning prosthetic mechanical mitral valve, pre-
served left ventricular ejection fraction, dilated right ventricle
with preserved systolic function (tricuspid annulus plane sys-
tolic excursion of 20 mm), a moderate tricuspid regurgitation
with an estimated pulmonary artery systolic pressure of
65 mmHg, and a severely dilated inferior vena cava (Figure
1A). Given that the patient had a mechanical mitral valve,
echocardiographic assessment of left ventricular end diastolic
pressures was not possible. The laboratory analysis showed
an N-terminal prohormone of brain natriuretic peptide of
3205 pg/mL and WRF, with an increase in serum creatinine
from 1.23 to 1.81 mg/dL (a decline in estimated glomerular fil-
tration rate from 45 to 27 mL/min/1.73 m2). A Doppler ultra-
sonography evaluating renal interlobar venous flow showed a
monophasic pattern (Figure 1B), suggesting a severe elevation
in intrarenal venous pressures.
In this case, according to physical and Doppler findings, re-
nal venous congestion appeared to be casually linked to the
occurrence of WRF. Accordingly, we started an aggressive in-
travenous diuretic treatment during the first 48 h (cumulative
furosemide dose of 500 mg). At this time, we reassessed the
echo-Doppler, registering a reduction of the diameter of infe-
rior vena cava (Figure 1C) and a change from monophasic to
biphasic venous flow pattern in the intrarenal ultrasonogra-
phy (Figure 1D), indicating an improvement in venous flow
and, therefore, a reduction of venous pressures. Importantly,
this change occurred in parallel with clinical improvement
(resolution of abdominal discomfort, 2 kg weight loss) and
an improvement in renal function (serum creatinine and esti-
mated glomerular filtration rate changed from 1.81 to
1.44 mg/dL and from 27 to 38 mL/min/1.73 m2, respectively).
Figure 1 Images of echocardiography performed at admission and at 48 h visit. (A) Inferior vena cava measurement at admission showing a diameter
of 2.85 cm. (B) Intrarenal venous flow* at admission showing a monophasic pattern. (C) Inferior vena cava measurement at admission at 48 h visit
showing a maximum diameter of 2.03 cm with inspiratory collapse of <50%. (D) Intrarenal venous flow* at 48 h visit showing a biphasic discontinuous
pattern. *Pulsed-wave Doppler signal of interlobar renal vessel recorded with the use of a commercially available system (Philips Healthcare) with a
sector transducer frequency range of 2.5 to 5 MHz. The upward Doppler signal corresponds to arterial flow (arrow head) and the downward Doppler
signal to venous flow (arrow).
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Changes in laboratory parameters after diuretic treatment
are shown in Figure S1.
Discussion
Intrarenal venous Doppler ultrasonography has been used for
years to evaluate non-cardiac conditions linked to elevated
interstitial renal pressure such as obstructive uropathy or di-
abetic nephropathy. However, recent evidence suggests the
potential application of this imaging modality for evaluating
intrarenal haemodynamics in heart failure.
Iida et al. evaluated the characteristics of intrarenal Dopp-
ler ultrasonography and their prognostic implications in a
cohort of stable, non-ischaemic heart failure patients.3 The
authors described three IRVF patterns (continuous, biphasic
discontinuous, and monophasic discontinuous) and corre-
lated each pattern with clinical, echocardiographic, and
haemodynamic (measured by right heart catheterization) var-
iables. Interestingly, the authors observed that the biphasic
and monophasic discontinuous patterns were associated with
increased right atrial pressure features and correlated
strongly with clinical outcomes independent of conventional
prognostic factors such as right atrial pressure levels and car-
diac index. In the same line, Nijst et al. evaluated the varia-
tions in IRVF signals after volume loading (1 L fluid
expansion over 3 h) and unloading in stable heart failure pa-
tients and control subjects.4 Continuous IRVF pattern was the
most common signal at baseline in both groups. However, af-
ter fluid administration, most of heart failure patients devel-
oped a biphasic pattern in contrast with control subjects
where no variations were observed. Interestingly, 1 h after
administration of intravenous diuretics, 70% of heart failure
patients returned to the baseline situation (continuous flow
pattern). Nevertheless, it is important to note that these
two studies were carried out in stable and euvolemic
patients.
To the best of our knowledge, this is the first report show-
ing a change in IRVF following aggressive depletive treatment
in a patient with ADHF and WRF on admission. Interestingly,
Doppler findings were correlated with clinical decongestion
and renal improvement.
Worsening renal function in the setting of ADHF has a
complex and multifactorial pathophysiology, which explains
why patients show mixed clinical response to treatment.5
Based on the findings by Iida et al. and Nijst et al., IRVF pat-
terns assessed by Doppler may have a role for identifying the
renal haemodynamic disturbances in patients with heart fail-
ure. We speculate that biphasic and monophasic discontinu-
ous venous flow patterns could help physicians to identify a
phenotype of ‘congestive renal failure’ in which an aggressive
decongestive therapy would be recommended. Conversely, a
continuous venous flow pattern would identify those with
normal renal venous pressures in which a more conservative
diuretic strategy should be indicated. Moreover, the dynamic
behaviour in response to therapy observed in our patient





Additional supporting information may be found online in the
Supporting Information section at the end of the article.
Figure S1. Changes in laboratory parameters after diuretic
treatment. (A) Glomerular filtration rate. (B) NT-proBNP. (C)
Hemoglobin. (D) Hematocrit. eGFR: estimated glomerular fil-
tration rate; NT-proBNP: amino-terminal pro-brain natriuretic
peptide.
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